Deep, qualified next-generation sequencing has revealed that subclonal mutations (i.e., those existing in just a fraction of tumor cells) may be detected for all driver genes and so are linked to swift illness development and lousy consequence.11–13 This is particularly pertinent for TP53 See "Specific therapies in CLL: mechanisms of https://mannersd333zsj4.wikikali.com/user